TIGARD, Ore.--(BUSINESS WIRE)--Bioject Medical Technologies Inc. (Pink Sheets:BJCT), an innovative developer and manufacturer of needle-free injection therapy systems, today reported unaudited financial results for the year and quarter ended December 31, 2011 and for the first quarter ended March 31, 2012. The financial results are unaudited and actual results may vary.
